Electroconvulsive Therapy: Part II: A Biopsychosocial Perspective

New York University (NYU), Silver School of Social Work , USA.
Journal of psychiatric practice 09/2009; 15(5):369-90. DOI: 10.1097/01.pra.0000361278.73092.85
Source: PubMed


The myths surrounding electroconvulsive therapy (ECT) and the misconceptions held by the general public, clinicians, and patients have interfered with acceptance of this treatment throughout its history. Misunderstandings surrounding ECT, and its consequent stigmatization, are reviewed, including negative depictions of ECT in film, print media, and on the Internet. Clinicians involved in the delivery of ECT benefit from gaining an understanding of how ECT may be perceived by patients and other mental health professionals; they can play a vital role in educating patients and helping ensure the delivery of a successful course of ECT. Guidance is provided for clinicians on how to support patients and families through the ECT process using a model team approach. Anxiety reduction, meeting individual needs, patient and family psychoeducation, assessment of psychosocial supports, and discharge planning are discussed.

Download full-text


Available from: Nancy Payne, Sep 10, 2014
  • Source
    • "In this section we summarize the history and evolution of ECT based on reviewing several excellent resources that the reader is referred to for more details [3] [4] [5] [6] [7] [8] [9]. ECT is the product of a complex set of circumstances. "

    Electroconvulsive Therapy: Clinical Uses, Efficacy and Long-Term Health Effects, Edited by Kathleen Braddock, 08/2014: chapter An Evidence-Informed Model for the Modern Practice of Electroconvulsive Therapy; NOVA scientific publisher., ISBN: 978-1-63463-038-2
  • Source
    • "For many years, ECT has been recognized as a highly effective treatment option for severe depression as well as acute mania and catatonia. Today, ECT continues to be investigated and refined (Deng, Lisanby, & Peterchev, 2009; Lisanby et al., 2003a, 2003b; Payne & Prudic, 2009a, b; Spellman, Peterchev, & Lisanby, 2009; Sackeim, et al., 2008), whereas new brain stimulation modalities have emerged, and other older methods have been updated. Nearly five decades passed before non-invasive and non-convulsive treatments were developed in the form of magnetic stimulation of the brain (Barker, Jalinous, & Freeston, 1985). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Posttraumatic stress disorder (PTSD) is a complex, heterogeneous disorder that develops following trauma and often includes perceptual, cognitive, affective, physiological, and psychological features. PTSD is characterized by hyperarousal, intrusive thoughts, exaggerated startle response, flashbacks, nightmares, sleep disturbances, emotional numbness, and persistent avoidance of trauma-associated stimuli. The efficacy of available treatments for PTSD may result in part from relief of associated depressive and anxiety-related symptoms in addition to treatment of core symptoms that derive from reexperiencing, numbing, and hyperarousal. Diverse, heterogeneous mechanisms of action and the ability to act broadly or very locally may enable brain stimulation devices to address PTSD core symptoms in more targeted ways. To achieve this goal, specific theoretical bases derived from novel, well-designed research protocols will be necessary. Brain stimulation devices include both long-used and new electrical and magnetic devices. Electroconvulsive therapy (ECT) and Cranial electrotherapy stimulation (CES) have both been in use for decades; transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), deep brain stimulation (DBS), transcranial Direct Current Stimulation (tDCS), and vagus nerve stimulation (VNS) have been developed recently, over approximately the past twenty years. The efficacy of brain stimulation has been demonstrated as a treatment for psychiatric and neurological disorders such as anxiety (CES), depression (ECT, CES, rTMS, VNS, DBS), obsessive-compulsive disorder (OCD) (DBS), essential tremor, dystonia (DBS), epilepsy (DBS, VNS), Parkinson Disease (DBS), pain (CES), and insomnia (CES). To date, limited data on brain stimulation for PTSD offer only modest guidance. ECT has shown some efficacy in reducing comorbid depression in PTSD patients but has not been demonstrated to improve most core PTSD symptoms. CES and VNS have shown some efficacy in reducing anxiety, findings that may suggest possible utility in relieving PTSD-associated anxiety. Treatment of animal models of PTSD with DBS suggests potential human benefit. Additional research and novel treatment options for PTSD are urgently needed. The potential usefulness of brain stimulation in treating PTSD deserves further exploration.
    European Journal of Psychotraumatology 10/2011; 2. DOI:10.3402/ejpt.v2i0.5609 · 2.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We present the case of a patient with treatment-refractory mania. The patient had been tried on numerous medications, to which she either did not respond well or on which she developed severe side effects, However, the patient improved rapidly when treated with unilateral electropercussive therapy (ECT) following a court order. We outline the legal barriers that have been raised against the use of ECT in patients with mania, who often refuse treatment, and the irony that ECT can be safer than medications for some patients. ECT is underutilized in mania but deserves more frequent consideration. (Journal of Psychiatric Practice. 2011;17:61-66).
    01/2011; 17(1):61-6. DOI:10.1097/01.pra.0000393847.58003.8f
Show more